Imaging Features of Tuberculosis Patients with Type 2 Diabetes, 2018-2023

87 primary type 2 diabetes patients with rifampicin-resistant/multidrug-resistant tuberculosis (T2DM RR/MDR-TB) are included in this dataset, alongside three other patient groups totaling 364 individuals. The data, collected from Dalian Public Health Clinical Center between 2018 and 2023, compares clinical features and pulmonary CT imaging findings across these groups. It was authored by Yuhua Zhao and published on figshare.

Use Cases

• Identify high-risk imaging factors for type 2 diabetes in RR/MDR-TB patients based on features like large nodules and multiple cavities.
• Analyze correlations between glycated hemoglobin (HbA1c) levels and specific CT findings such as pleural effusion.
• Compare demographic and clinical characteristics like BMI and albumin levels across patient groups with different tuberculosis and diabetes statuses.

Strengths

• Includes 364 patient records across four distinct clinical groups for comparative analysis.
• Data covers a 5-year period from 2018 to 2023 from a single clinical center.
• Analysis includes specific imaging features like patchy opacities and non-calcified lymph node enlargement.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect geographic bias inherent to its collection from a single center in Dalian.

Provenance

Source

Dalian Public Health Clinical Center

Collection Method

Clinical data and pulmonary CT findings were collected from patient records.

Time Range

2018 to 2023

Freshness

Last updated 2026-05-22 05:34:18; freshness should be verified.

Geography

Dalian, China (likely)